Impaired respiratory burst contributes to infections in PKCδ-deficient patients.
Journal
The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R
Informations de publication
Date de publication:
06 09 2021
06 09 2021
Historique:
received:
02
03
2021
revised:
14
05
2021
accepted:
21
06
2021
entrez:
15
7
2021
pubmed:
16
7
2021
medline:
25
11
2021
Statut:
ppublish
Résumé
Patients with autosomal recessive protein kinase C δ (PKCδ) deficiency suffer from childhood-onset autoimmunity, including systemic lupus erythematosus. They also suffer from recurrent infections that overlap with those seen in patients with chronic granulomatous disease (CGD), a disease caused by defects of the phagocyte NADPH oxidase and a lack of reactive oxygen species (ROS) production. We studied an international cohort of 17 PKCδ-deficient patients and found that their EBV-B cells and monocyte-derived phagocytes produced only small amounts of ROS and did not phosphorylate p40phox normally after PMA or opsonized Staphylococcus aureus stimulation. Moreover, the patients' circulating phagocytes displayed abnormally low levels of ROS production and markedly reduced neutrophil extracellular trap formation, altogether suggesting a role for PKCδ in activation of the NADPH oxidase complex. Our findings thus show that patients with PKCδ deficiency have impaired NADPH oxidase activity in various myeloid subsets, which may contribute to their CGD-like infectious phenotype.
Identifiants
pubmed: 34264265
pii: 212473
doi: 10.1084/jem.20210501
pmc: PMC8288504
pii:
doi:
Substances chimiques
Protein Isoforms
0
NADPH Oxidases
EC 1.6.3.-
PRKCD protein, human
EC 2.7.11.13
Protein Kinase C-delta
EC 2.7.11.13
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Department of Health
Pays : United Kingdom
Organisme : NIH HHS
ID : 8UL1TR001866
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI095983
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127564
Pays : United States
Organisme : NCRR NIH HHS
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006504
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1HG006504
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI095983
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI089970
Pays : United States
Organisme : NIAID NIH HHS
ID : 5R01AI089970
Pays : United States
Informations de copyright
© 2021 Neehus et al.
Déclaration de conflit d'intérêts
Disclosures: P.A. Brogan reported personal fees from Sobi, Novartis, Roche, and GSK, and grants from Sobi outside the submitted work. No other disclosures were reported.
Références
Clin Infect Dis. 2015 Apr 15;60(8):1176-83
pubmed: 25537876
Medicine (Baltimore). 2000 May;79(3):170-200
pubmed: 10844936
J Allergy Clin Immunol. 2019 Feb;143(2):782-785.e1
pubmed: 30312704
Autoimmun Rev. 2017 Sep;16(9):897-902
pubmed: 28694138
Stem Cells. 2017 Apr;35(4):898-908
pubmed: 28090699
Mol Cancer Res. 2007 Jun;5(6):627-39
pubmed: 17579121
J Biol Chem. 1995 Sep 15;270(37):21852-9
pubmed: 7665608
J Biol Chem. 1998 Nov 13;273(46):30097-103
pubmed: 9804763
Nat Rev Cancer. 2007 Apr;7(4):281-94
pubmed: 17384583
J Mol Cell Cardiol. 2011 Nov;51(5):665-73
pubmed: 21810427
J Allergy Clin Immunol. 2015 May;135(5):1393-5.e1
pubmed: 25542884
Oncogene. 2008 May 8;27(21):3045-53
pubmed: 18059334
J Biol Chem. 1994 Jan 28;269(4):2349-52
pubmed: 7507923
Mol Cell Biol. 2014 Apr;34(8):1474-85
pubmed: 24515435
FASEB J. 1995 Apr;9(7):484-96
pubmed: 7737456
Blood. 2013 Apr 18;121(16):3117-25
pubmed: 23430113
Sci Immunol. 2018 Jun 15;3(24):
pubmed: 29907691
Autoimmun Rev. 2019 Oct;18(10):102361
pubmed: 31401343
Int J Mol Sci. 2019 Mar 26;20(6):
pubmed: 30917487
Nature. 2004 Sep 23;431(7007):456-61
pubmed: 15361883
Medicine (Baltimore). 2000 May;79(3):155-69
pubmed: 10844935
Exp Mol Med. 2009 Apr 30;41(4):217-25
pubmed: 19372727
J Clin Immunol. 2016 Oct;36(7):631-40
pubmed: 27541826
FEBS Lett. 2007 Jul 24;581(18):3377-81
pubmed: 17603046
Blood. 2013 Apr 18;121(16):3112-6
pubmed: 23319571
Nat Med. 2016 Feb;22(2):146-53
pubmed: 26779811
Genes Dis. 2019 Jul 27;7(1):84-92
pubmed: 32181279
J Immunol. 2004 Nov 1;173(9):5730-8
pubmed: 15494525
Arthritis Rheum. 2013 Aug;65(8):2161-71
pubmed: 23666743
J Biol Chem. 1997 Jan 10;272(2):952-60
pubmed: 8995387
Chem Rev. 2001 Aug;101(8):2353-64
pubmed: 11749377
J Leukoc Biol. 2016 Sep;100(3):581-8
pubmed: 26965632
Nature. 1986 Jul 3-9;322(6074):32-8
pubmed: 2425263
Shock. 2019 May;51(5):538-547
pubmed: 30095599
J Biol Chem. 2007 Aug 3;282(31):22307-14
pubmed: 17562707
J Pediatr. 2019 Jul;210:220-225
pubmed: 31027832
Blood. 2010 Dec 23;116(26):6027-36
pubmed: 20861461
Mol Cell. 2003 Jan;11(1):35-47
pubmed: 12535519
J Clin Immunol. 2015 Aug;35(6):523-6
pubmed: 26233237
Biochemistry. 2002 Jun 18;41(24):7743-50
pubmed: 12056906
J Infect. 2012 Jun;64(6):543-54
pubmed: 22430715
N Engl J Med. 2008 Feb 28;358(9):929-39
pubmed: 18305268
J Biol Chem. 2001 Aug 31;276(35):32407-10
pubmed: 11432875
Curr Opin Immunol. 2008 Dec;20(6):632-8
pubmed: 18848883
Pediatrics. 2017 Jan;139(1):
pubmed: 28003329
Immunol Invest. 2020 Oct 13;:1-12
pubmed: 33047643
Curr Protoc Immunol. 2016 Nov 1;115:7.21C.1-7.21C.12
pubmed: 27801513
J Leukoc Biol. 2005 Mar;77(3):414-20
pubmed: 15591124
Pediatr Blood Cancer. 2015 Dec;62(12):2101-7
pubmed: 26185101
J Allergy Clin Immunol. 2021 Feb;147(2):520-531
pubmed: 32980424
Stem Cell Reports. 2018 Jan 9;10(1):7-16
pubmed: 29249666
Eur J Clin Invest. 2018 Nov;48 Suppl 2:e12951
pubmed: 29757466
Clin Mol Allergy. 2011 May 31;9(1):10
pubmed: 21624140
ScientificWorldJournal. 2010 Nov 16;10:2272-84
pubmed: 21103796
J Allergy Clin Immunol. 2016 Jul;138(1):241-248.e3
pubmed: 26936803
Nature. 2002 Apr 25;416(6883):865-9
pubmed: 11976687
J Biol Chem. 2014 Aug 15;289(33):22759-22770
pubmed: 24970888
J Clin Invest. 2018 Aug 31;128(9):3957-3975
pubmed: 29969437
Nat Immunol. 2011 May;12(5):425-33
pubmed: 21441934
Pediatr Dermatol. 2016 Mar-Apr;33(2):e114-20
pubmed: 27001332
Curr Opin Immunol. 2004 Jun;16(3):367-73
pubmed: 15134787
Biochem Biophys Res Commun. 2001 Oct 5;287(4):1009-16
pubmed: 11573965
Blood Cells Mol Dis. 2005 Sep-Oct;35(2):291-302
pubmed: 16102984
Nat Immunol. 2011 Mar;12(3):213-21
pubmed: 21278736
Cell. 1995 Jun 16;81(6):917-24
pubmed: 7781068
Nature. 2002 Apr 25;416(6883):860-5
pubmed: 11976686
Curr Opin Immunol. 2017 Dec;49:87-95
pubmed: 29100097
J Intern Med. 1990 Mar;227(3):207-10
pubmed: 1690258
Nature. 1987 Jun 25-Jul 1;327(6124):717-20
pubmed: 3600768
Ann N Y Acad Sci. 2011 Nov;1238:91-8
pubmed: 22129056
Pediatr Rheumatol Online J. 2018 Sep 26;16(1):61
pubmed: 30257684
J Allergy Clin Immunol. 2015 Nov;136(5):1404-7.e1-10
pubmed: 26233929
Stem Cell Reports. 2015 Feb 10;4(2):282-96
pubmed: 25680479
J Biol Chem. 1999 Jul 2;274(27):19115-23
pubmed: 10383415
Structure. 1998 Jul 15;6(7):885-94
pubmed: 9687370
Immunology. 2020 Jun;160(2):126-138
pubmed: 31715003
J Leukoc Biol. 1999 Nov;66(5):851-7
pubmed: 10577519
Blood. 2009 Oct 8;114(15):3309-15
pubmed: 19692703
J Biol Chem. 2012 Nov 2;287(45):37891-906
pubmed: 22988234
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16251-6
pubmed: 17913887